With the dynamic landscape of healthcare law compliance, the responsibility associated with meeting industry challenges and regulatory constraints expands. Oftentimes such responsibilities are burdensome; largely a result of the secondary nature in which they become part of an individual’s workload.
In late 2014, Medicines Australia adopted a new code of conduct, Edition 18, which applies to pharmaceutical companies and took effect in January of 2015. Among many subtle changes to theRead more
Pharmaceutical Executive Magazine recently published an article about domestic and global compliance challenges for the life sciences industry entitled “Compliance at the Cross-Border Crossroads”. Several key industry leaders were quotedRead more
In the June, 2015 issue of the Life Science Compliance Update, David Davidovic, a Senior Advisor to Polaris Management contributed an interesting article about "The Importance of The Front EndRead more